PERT Consortium 2021
S

Regulatory Pathways for Devices for Management of Pulmonary Embolism: FDA Perspectives

By PERT Consortium 2021 FEATURING Steven Lossef
By PERT Consortium 2021 FEATURING Steven Lossef
164 views
December 31, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

27:07
Boston Scientific

Advanced Endovascular Management of Pulmonary Embolism: What Does RE…

Feat. P. Monteleone

Featured Video

27:07
Boston Scientific

Advanced Endovascular Management of Pulmonary Embolism: What Does RE…

Feat. P. Monteleone

Related Content

AUTOPLAY
NYU Langone

Advanced Heart Failure Cases and Controversies

Fri, May 10, 2024
Scripps Health

Cardiovascular Atherosclerosis: Prediction, Prevention and Management

Sat, May 18, 2024
Stanford Medicine

5th Annual Conference on Disability in Healthcare and Medicine

Sat, Apr 27, 2024
The Texas Heart Institute

Perfusion Conference 2024

Fri, Jun 7, 2024
See 3 others
UPMC

UPMC Hamot 2024 Cardiovascular Update

Fri, May 10, 2024
See 1 other
Cardiometabolic Health Congress (CMHC)

19th Annual Congress

Thu, Oct 17, 2024
Precision Cardiovascular Care 2024: Transitioning Care from Phenotypes to Genotypes

Precision Cardiovascular Care 2024: Transitioning Care from Phenotyp…

Fri, May 3, 2024
Venous Symposium

Venous Symposium 2024

Wed, May 8, 2024
American Academy of Anti-Aging Medicine

32nd Annual Spring Congress: The Metabolic Crisis

Fri, May 3, 2024
American Society of Nuclear Cardiology

Cardiac PET Intensive Virtual Workshop

Sat, Jun 1, 2024
See 1 other
Controversies in Interventional Cardiovascular Therapies - CICT 2024

Controversies in Interventional Cardiovascular Therapies - CICT 2024

Fri, Jul 26, 2024
The American Society for Preventive Cardiology

ASPC 2024 Congress on CVD Prevention

Fri, Aug 2, 2024
Didactic Presentations

30th Annual San Diego Heart Failure Symposium: Advances in the Recog…

Fri, Jul 19, 2024
14:59
PERT Consortium 2021

New European Guidelines on Pulmonary Embolism: What Has Changed and …

Feat. S. Konstantinides
07:19
CVRx | Barostim

Considering Quality of Life as Part of Patient Selection for Heart F…

Feat. L. Grazette
12:50
AVA at Your Fingertips

Lessons Learned From Trials of Implementation: The CLABSI Section of…

Feat. V. Chopra
35:06
The New Orleans Conference

What Is Truly Informed Consent and Should The Perfusionist Get His/H…

13:25
TCT 2022 Conference Coverage

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

Feat. W. Jaber
16:30
Penumbra, Inc.

Treating PE in My Practice

Feat. R. Lookstein
11:39
Mount Sinai Endovascular Fellows Course

Catheter-Based Interventions for Acute Pulmonary Embolism: What Are …

Feat. J. Giri
08:01
PERT Consortium 2022

Update on HI-PEITHO - A Landmark Clinical Trial in PE

Feat. K. Rosenfield
12:18
PERT Consortium 2022

Catheter-Directed Thrombolysis Is the Preferred Approach for the Tre…

Feat. P. Monteleone
30:09
Innovations in Cardiovascular Therapeutics 2016

Understanding the changing landscape of cardiovascular economics

11:19
PERT Consortium 2021

Regulatory Pathways for PE Management: Panel Discussion

Feat. K. Rosenfield, B. Keeling, S. Lossef, T. Bowers, E. Secemsky
12:45
American Society of Echocardiography

Strategies to Reduce Low Value Care

Feat. G. Rose
08:20
PERT Consortium 2021

Interventions for PE in 2021: Papers You Need to Know

Feat. J. Moriarty
36:21
Scripps Health

Shock with Pulmonary Embolism

Feat. C. Stinis
14:33
TCT 2023 Insights

TCT 2023 Insights: Catheter Interventions for Severe PE – Clinical T…

Feat. A. Sista
15:10
Boston Scientific

TCT 2023: REAL-PE: New Perspectives on Endovascular Strategies for P…

Feat. M. Jaff, P. Monteleone, R. Ahern, J. Mirviss, S. Parikh
21:06
Boston Scientific

EKOS Therapy and Mechanical Thrombectomy in PE: Part 1 - What Does P…

Feat. K. Sterling, P. Troy, A. Messerli
17:53
ARCH Advanced Revascularization Symposium

What's New in Interventional Pulmonary Embolism Therapy?

Feat. T. Tu
20:27
University of Miami

PE Interventions: Patient and Device Selection

Feat. S. Afanador
05:35
Inari Medical

Addressing High-Risk PE: Rationale and Results of the FLAME Study

Feat. J. Horowitz